Margo B Gerke - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Margo B Gerke

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Cancers|August 12, 2023

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative NeoplasmsMargo B Gerke, Ilias Christodoulou, Theodoros Karantanos

Cancers|June 27, 2024

Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic ImplicationsMargo B Gerke, Caroline S Jansen, Mehmet A Bilen

Immunotherapy|January 24, 2024

Established and emerging biomarkers of immunotherapy in renal cell carcinomaYash Jani, Caroline S Jansen, Margo B Gerke, et al.

Cancer|April 16, 2026

Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Yuan Liu, et al.

The Oncologist|July 11, 2026

Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Michelle Jayaraj, et al.

Pageof 1

Search research articles

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Cancers|August 12, 2023

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative NeoplasmsMargo B Gerke, Ilias Christodoulou, Theodoros Karantanos

Cancers|June 27, 2024

Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic ImplicationsMargo B Gerke, Caroline S Jansen, Mehmet A Bilen

Immunotherapy|January 24, 2024

Established and emerging biomarkers of immunotherapy in renal cell carcinomaYash Jani, Caroline S Jansen, Margo B Gerke, et al.

Cancer|April 16, 2026

Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Yuan Liu, et al.

The Oncologist|July 11, 2026

Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Michelle Jayaraj, et al.

Pageof 1